Filing Details
C4 Therapeutics, Inc. (NASDAQ:CCCC) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:CCCC
C4 Therapeutics, Inc. (CCCC) Files Quarterly Report for Q0
C4 Therapeutics, Inc. (NASDAQ:CCCC) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
At publication ·
What changed
C4 Therapeutics, Inc. (NASDAQ:CCCC) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- C4 Therapeutics, Inc. (NASDAQ: CCCC) filed its quarterly report (Form 10-Q) with the SEC on August 11, 2026.
- The company's stock trades at $3.87 with a market capitalization of $180.4 million.
- The 10-Q filing contains unaudited financial statements and management commentary on recent performance, including emerging trends and updated risk factors.
Market Context
C4 Therapeutics, Inc.'s stock currently trades at $3.87 with a market capitalization of $180.4M.
The 10-Q provides C4 Therapeutics, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for C4 Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CCCC Stock Page
Frequently Asked Questions
Where can I read CCCC's SEC filings?
Browse all filings on our CCCC SEC filings page.
What types of SEC filings does C4 Therapeutics, Inc. file?
Public companies like C4 Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.